NewLink Genetics Corporation (NLNK)

[Clonefan]

First Eagle Investment (Trades, Portfolio) currently owns 327 stocks with a total value of $39.676 billion.

In the fourth quarter of 2015, First Eagle Investment (Trades, Portfolio) added 2,615,229 shares of NewLink Genetics Corp. (NLNK).

NewLink Genetics was originally founded in Delaware in 1999. NewLink Genetics is a biopharmaceutical company that focuses on discovering, developing, and commercializing novel immuno-oncology products to help improve the lives of cancer patients.

NewLink Genetics has a market cap of $740.07 million, a P/E ratio of 10.58, an enterprise value of $543.92 million and a quick ratio of 19.37.

Below is a Peter Lynch chart for NewLink Genetics Corp.

https://finance.yahoo.com/news/first-eagle-investment-adds-stake-202040762.html

NewLink Genetics has a few good signs according to GuruFocus.

The company's Piotroski F-score is high with a ranking of 7, which indicates a very healthy financial situation. NewLink Genetics has a comfortable interest rate coverage of 5 and a quick ratio of 19.37, meaning they have enough cash to cover all of their debt. The price of the company is also close to a one-year low.

I believe that NewLink Genetics is a good investment because the company has numerous good signs with strong operating margins. The company is also doing something positive to help improve the lives of patients with cancer.